FDA 510(k)

DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8

K-Number: K855110 · 1986-01-07

ApplicantGibco Laboratories Life Technologies, Inc.

Decision Date1986-01-07

Product CodeJSI

Advisory CommitteeMI

DecisionSubstantially Equivalent

Device Summary

DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8 is the device name listed in this FDA 510(k) record. The listed applicant is Gibco Laboratories Life Technologies, Inc.. It received FDA 510(k) clearance on 1986-01-07 under 510(k) number K855110. The device is classified under product code JSI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8?

DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8 is a medical device that received FDA 510(k) clearance on 1986-01-07. The listed applicant is Gibco Laboratories Life Technologies, Inc.. The 510(k) number is K855110.

When did DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8 receive FDA 510(k) clearance?

DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8 received FDA 510(k) clearance on 1986-01-07, under 510(k) number K855110.

Who is the listed applicant for DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8?

The FDA 510(k) record lists Gibco Laboratories Life Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8?

The FDA product code for DRI-FORM UREAPLASMA DIFFERENTIAL BASAL AGAR MED.A8 is JSI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Gibco Laboratories Life Technologies, Inc. as applicant

K871855SORBITOL MACCONKEY (SMAC) AGAR, DRI & PRE-FORM K871541MARTIN-LEWIS AGAR W/REDUCED VANCOMYCIN C0226 K870134MCBRIDE LISTERIA AGAR W/CYCLOHEXIMIDE, DRI & PRE K864755PSEUDOMONAS CEPACIA SELECTIVE AGAR, DRI & PRE-FORM K864014LOMBARD DOWELL AGAR BASE K863821MUELLER HINTON AGAR W/4%NACL AND OXACILLIN

View all 67 devices →

Related Devices (Code: JSI)

K070691BBL CHROMAGAR 0157Becton, Dickinson & CO K974428DIPSTREAKNovamed , Ltd.K891593LISTERIA SELECTIVE ENRICHMENT MEDIUMOxoid U.S.A., Inc.K890199DENTOCULT SM-STRIP MUTANSOrion Corp.K882182SALMONELLA-SHIGELLA (SS) AGAR - PRODUCT #P3326Lakewood Biochemical Co., Inc.K881575SELECTIVE STREPTOCOCCUS AGARAcumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.